Colorectal Cancer Molecular Diagnostics Market Snapshot 2022 to 2032
[306 Pages Report] The global colorectal cancer molecular diagnostics market garnered a market value of US$ 2.35 Billion in 2022 and is expected to accumulate a market value of US$ 5.07 Billion by registering a CAGR of 8% in the assessment period 2022-2032. Growth of the market can be attributed to increasing cases of cancer along with development in diagnostic laboratories.
Report Attribute
Details
Estimated Base Year Value (2021)
US$ 2.17 Billion
Expected Market Value (2022)
US$ 2.35 Billion
Anticipated Forecast Value (2032)
US$ 5.07 Billion
Projected Growth Rate (2022 to 2032)
8% CAGR
Approximately 1.4 million new cases of colorectal cancer are diagnosed each year. Obtaining an early diagnosis is critical as it is currently one of the deadliest cancers, totalling more than 600,000 deaths each year.
Colorectal cancer molecular diagnostics can speed up the identification of colorectal cancer to provide patients with more treatment options. Individualized and targeted treatments are reshaping the colorectal molecular diagnostics market. Molecular pathology is a key factor in personalized medicine. This, in turn, is increasing the dependency on colorectal cancer molecular diagnostics.
Increasing adoption of high throughput sequencing technologies and identification of therapeutic targets has led to the development of many colorectal molecular diagnostic tests, which are superior to the conventional colorectal cancer molecular diagnostics tests.
Positive market trends and increasing investor confidence in several key players are helping mergers and acquisition activities in the colorectal cancer molecular diagnostics market. The disruption in the global healthcare market due to political factors such as the Obama Care Act, and regulatory framework changes, and other trade barriers, are anticipated to trigger merger and acquisition activities to drive the colorectal cancer molecular diagnostics market consolidation and further intensify the market competition.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Which are Some Prominent Drivers Accelerating the Growth of Colorectal Cancer Molecular Diagnostics?
Increase in research in the pharmaceutical and biotechnology industry is contributing to the growth of the colorectal cancer molecular diagnostics market significantly. In addition, growing automation in laboratories is another factor supporting the growth of the colorectal cancer molecular diagnostics market.
Moreover, the ease of use of colorectal cancer molecular diagnostics, as well as accurate results is supporting the growth of the colorectal cancer molecular diagnostics market. All these factors are increasing the use of colorectal cancer molecular diagnostics.
What are the Challenges Faced by the Colorectal Cancer Molecular Diagnostics Market?
Despite colorectal cancer being common across the globe, many people do not get themselves tested at an early stage. This is owing to the lack of knowledge regarding the problem and its lasting effects on health. In addition, the availability of low-cost alternatives and the high cost of instruments may hinder the growth of the market during the forecast period.
Limited specificity to some diagnostics tests that are unable to distinguish between inflammation and actual symptoms or cancer is another issue being faced by the colorectal cancer molecular diagnostics market.
Find your sweet spots for generating winning opportunities in this market.
Increasing Cases of Colorectal Cancer Augmenting Growth of Colorectal Cancer Molecular Diagnostics Market in North America?
American Cancer Society states that 52,580 deaths are expected to occur due to colorectal cancer in 2022 in U.S. the number of people being diagnosed with colorectal cancer is increasing owing to habits such as smoking, drastic diet changes and stress. Moreover, people suffering from hereditary cancer diseases are likely to suffer from cancer in the region. As the awareness regarding getting diagnosed is increasing, more people have shown an inclination to undergo tests. Furthermore, owing to the increasing automation of labs in the region is positively Inflcuening the growth of the market.
Thus, North America is expected to hold the maximum market share and is expected to register a CAGR of 9% for the global colorectal cancer molecular diagnostics market.
Government Initiatives Contributing to the Growth of Colorectal Cancer Molecular Diagnostics Market in Asia Pacific?
The strong and evolving government support towards research in biotechnology and pharmaceutical industry in Asia Pacific especially in countries like India and China are contributing to the growth of colorectal cancer molecular diagnostics. Reports state that the number of people suffering from colorectal cancer are expected to increase by 2035, especially in India.
Thus, the government of the country is taking measures to spread awareness amongst people to get tested at an early stage. The Asia Pacific colorectal cancer molecular diagnostics market is anticipated to grow at a rapid pace with a maximum CAGR of more than 8% over the forecast period.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need and save 40%!
Market Competition
Some of the key players in the global Colorectal Cancer Molecular Diagnostics market are Dako, Gen Probe (Hologic), Cepheid, Qiagen, Roche Diagnostics, Bayer Healthcare, Abbott Laboratories, Grifols, Guardant Health, Danaher Corporation, Siemens, Beckton Dickinson, Biomérieux Sa, and Sysmex Corporation. Attributed to the presence of such high number of participants, the market is highly competitive.
In May 2022, Guardant Health launched a shield test that simply draws blood to detect the presence of cancer. This test does not require sedation, dietary changes and is less painful. The shield test detects early signs of colorectal cancer signals in the bloodstream.
Report Scope
Report Attribute
Details
Growth Rate
CAGR of 8% from 2022 to 2032
Market Value in 2022
US$ 2.35 Billion
Market Value in 2032
US$ 5.07 Billion
Base Year for Estimation
2021
Historical Data
2017 to 2021
Forecast Period
2022 to 2032
Quantitative Units
Revenue in USD Million and CAGR from 2022 to 2032
Report Coverage
Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis
Segments Covered
Product Type
Technology
End User
Region
Regions Covered
North America
Latin America
Europe
Asia Pacific
Middle East and Africa
Key Countries Profiled
USA
Canada
Brazil
Mexico
Germany
UK
France
Spain
Italy
Nordics
BENELUX
Australia & New Zealand
China
India
ASEAN
GCC
South Africa
Key Companies Profiled
Dako
Gen Probe (Hologic)
Cepheid Qiagen
Roche Diagnostics
Bayer Healthcare
Abbott Laboratories
Grifols, Danaher Corporation
Siemens
Beckton Dickinson
Biomérieux Sa
Guardant Health
Sysmex Corporation
Customization
Available Upon Request
Key Segments Profiled in the Colorectal Cancer Molecular Diagnostics Industry Survey
Colorectal Cancer Molecular Diagnostics Market by Product Type:
Colorectal Cancer Molecular Diagnostic Instruments
Colorectal Cancer Molecular Diagnostic Reagents & Kits
Colorectal Cancer Molecular Diagnostic Services
Colorectal Cancer Molecular Diagnostics Market by Technology:
PCR-based Colorectal Cancer Molecular Diagnostics
Sequencing-based Colorectal Cancer Molecular Diagnostics
Mass Spectrometry-based Colorectal Cancer Molecular Diagnostics
Transcription Mediated Amplification-based Colorectal Cancer Molecular Diagnostics
Chips and Microarrays-based Colorectal Cancer Molecular Diagnostics
Colorectal Cancer Molecular Diagnostics Market by End User:
Colorectal Cancer Molecular Diagnostics in Hospitals
Colorectal Cancer Molecular Diagnostics in Ambulatory Surgical Centers
Colorectal Cancer Molecular Diagnostics in Diagnostic Laboratories
Colorectal Cancer Molecular Diagnostics in Homecare Settings
Colorectal Cancer Molecular Diagnostics Market by Region:
North America Colorectal Cancer Molecular Diagnostics Market
Latin America Colorectal Cancer Molecular Diagnostics Market
Europe Colorectal Cancer Molecular Diagnostics Market
Asia Pacific Colorectal Cancer Molecular Diagnostics Market
Middle East & Africa Colorectal Cancer Molecular Diagnostics Market
Frequently Asked Questions
FMI projects the global colorectal cancer molecular diagnostics market to expand at an 8% value CAGR by 2032
North America is expected to be the most opportunistic colorectal cancer molecular diagnostics market, expanding at a 9% CAGR
Dako, Gen Probe (Hologic), Cepheid, Qiagen, Roche Diagnostics, Bayer Healthcare, Abbott Laboratories, Grifols, Danaher Corporation, Siemens, Beckton Dickinson, Biomérieux Sa, and Sysmex Corporation are some prominent colorectal cancer molecular diagnostics market.
Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. Value Chain Analysis
3.5.1. Profit Margin Analysis
3.5.2. Service Providers
3.6. PESTLE and Porter’s Analysis
3.7. Regulatory Landscape
3.7.1. By Key Regions
3.7.2. By Key Countries
3.8. Regional Parent Market Outlook
4. Global Colorectal Cancer Molecular Diagnostics Market Analysis 2017-2021 and Forecast, 2022-2032
4.1. Historical Market Size Value (US$ Mn) Analysis, 2017-2021
4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Colorectal Cancer Molecular Diagnostics Market Analysis 2017-2021 and Forecast 2022-2032, By Product Type
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Mn) Analysis By Product Type, 2017-2021
5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Product Type, 2022-2032
5.3.1. Colorectal Cancer Molecular Diagnostic Instruments
5.3.2. Colorectal Cancer Molecular Diagnostic Reagents & Kits
5.3.3. Services
5.4. Y-o-Y Growth Trend Analysis By Product Type, 2017-2021
5.5. Absolute $ Opportunity Analysis By Product Type, 2022-2032
6. Global Colorectal Cancer Molecular Diagnostics Market Analysis 2017-2021 and Forecast 2022-2032, By Technology
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Mn) Analysis By Technology, 2017-2021
6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Technology, 2022-2032
6.3.1. PCR
6.3.2. Sequencing
6.3.3. Mass Spectrometry
6.3.4. Transcription Mediated Amplification
6.3.5. Chips and Microarrays
6.3.6. Isothermal Nucleic Acid Amplification Technology
6.4. Y-o-Y Growth Trend Analysis By Technology, 2017-2021
6.5. Absolute $ Opportunity Analysis By Technology, 2022-2032
7. Global Colorectal Cancer Molecular Diagnostics Market Analysis 2017-2021 and Forecast 2022-2032, By End User
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Mn) Analysis By End User, 2017-2021
7.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By End User, 2022-2032
7.3.1. Hospitals
7.3.2. Ambulatory Surgical Centers
7.3.3. Diagnostic Laboratories
7.3.4. Homecare Settings
7.4. Y-o-Y Growth Trend Analysis By End User, 2017-2021
7.5. Absolute $ Opportunity Analysis By End User, 2022-2032
8. Global Colorectal Cancer Molecular Diagnostics Market Analysis 2017-2021 and Forecast 2022-2032, By Region
8.1. Introduction
8.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2017-2021
8.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. East Asia
8.3.5. South Asia & Pacific
8.3.6. MEA
8.4. Market Attractiveness Analysis By Region
9. North America Colorectal Cancer Molecular Diagnostics Market Analysis 2017-2021 and Forecast 2022-2032, By Country
9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
9.2.1. By Country
9.2.1.1. U.S.
9.2.1.2. Canada
9.2.2. By Product Type
9.2.3. By Technology
9.2.4. By End User
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Product Type
9.3.3. By Technology
9.3.4. By End User
9.4. Key Takeaways
10. Latin America Colorectal Cancer Molecular Diagnostics Market Analysis 2017-2021 and Forecast 2022-2032, By Country
10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
10.2.1. By Country
10.2.1.1. Mexico
10.2.1.2. Brazil
10.2.1.3. Rest of Latin America
10.2.2. By Product Type
10.2.3. By Technology
10.2.4. By End User
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Product Type
10.3.3. By Technology
10.3.4. By End User
10.4. Key Takeaways
11. Europe Colorectal Cancer Molecular Diagnostics Market Analysis 2017-2021 and Forecast 2022-2032, By Country
11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
11.2.1. By Country
11.2.1.1. Germany
11.2.1.2. Italy
11.2.1.3. France
11.2.1.4. U.K.
11.2.1.5. Spain
11.2.1.6. BENELUX
11.2.1.7. Russia
11.2.1.8. Rest of Europe
11.2.2. By Product Type
11.2.3. By Technology
11.2.4. By End User
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Product Type
11.3.3. By Technology
11.3.4. By End User
11.4. Key Takeaways
12. East Asia Colorectal Cancer Molecular Diagnostics Market Analysis 2017-2021 and Forecast 2022-2032, By Country
12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
12.2.1. By Country
12.2.1.1. China
12.2.1.2. Japan
12.2.1.3. South Korea
12.2.2. By Product Type
12.2.3. By Technology
12.2.4. By End User
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Product Type
12.3.3. By Technology
12.3.4. By End User
12.4. Key Takeaways
13. South Asia & Pacific Colorectal Cancer Molecular Diagnostics Market Analysis 2017-2021 and Forecast 2022-2032, By Country
13.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
13.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
13.2.1. By Country
13.2.1.1. India
13.2.1.2. ASEAN
13.2.1.3. Australia and New Zealand
13.2.1.4. Rest of South Asia & Pacific
13.2.2. By Product Type
13.2.3. By Technology
13.2.4. By End User
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Product Type
13.3.3. By Technology
13.3.4. By End User
13.4. Key Takeaways
14. MEA Colorectal Cancer Molecular Diagnostics Market Analysis 2017-2021 and Forecast 2022-2032, By Country
14.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
14.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
14.2.1. By Country
14.2.1.1. GCC Countries
14.2.1.2. Turkey
14.2.1.3. South Africa
14.2.1.4. Rest of MEA
14.2.2. By Product Type
14.2.3. By Technology
14.2.4. By End User
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Product Type
14.3.3. By Technology
14.3.4. By End User
14.4. Key Takeaways
15. Key Countries Colorectal Cancer Molecular Diagnostics Market Analysis
15.1. U.S.
15.1.1. Pricing Analysis
15.1.2. Market Share Analysis, 2021
15.1.2.1. By Product Type
15.1.2.2. By Technology
15.1.2.3. By End User
15.2. Canada
15.2.1. Pricing Analysis
15.2.2. Market Share Analysis, 2021
15.2.2.1. By Product Type
15.2.2.2. By Technology
15.2.2.3. By End User
15.3. Mexico
15.3.1. Pricing Analysis
15.3.2. Market Share Analysis, 2021
15.3.2.1. By Product Type
15.3.2.2. By Technology
15.3.2.3. By End User
15.4. Brazil
15.4.1. Pricing Analysis
15.4.2. Market Share Analysis, 2021
15.4.2.1. By Product Type
15.4.2.2. By Technology
15.4.2.3. By End User
15.5. Germany
15.5.1. Pricing Analysis
15.5.2. Market Share Analysis, 2021
15.5.2.1. By Product Type
15.5.2.2. By Technology
15.5.2.3. By End User
15.6. Italy
15.6.1. Pricing Analysis
15.6.2. Market Share Analysis, 2021
15.6.2.1. By Product Type
15.6.2.2. By Technology
15.6.2.3. By End User
15.7. France
15.7.1. Pricing Analysis
15.7.2. Market Share Analysis, 2021
15.7.2.1. By Product Type
15.7.2.2. By Technology
15.7.2.3. By End User
15.8. U.K.
15.8.1. Pricing Analysis
15.8.2. Market Share Analysis, 2021
15.8.2.1. By Product Type
15.8.2.2. By Technology
15.8.2.3. By End User
15.9. Spain
15.9.1. Pricing Analysis
15.9.2. Market Share Analysis, 2021
15.9.2.1. By Product Type
15.9.2.2. By Technology
15.9.2.3. By End User
15.10. BENELUX
15.10.1. Pricing Analysis
15.10.2. Market Share Analysis, 2021
15.10.2.1. By Product Type
15.10.2.2. By Technology
15.10.2.3. By End User
15.11. Russia
15.11.1. Pricing Analysis
15.11.2. Market Share Analysis, 2021
15.11.2.1. By Product Type
15.11.2.2. By Technology
15.11.2.3. By End User
15.12. China
15.12.1. Pricing Analysis
15.12.2. Market Share Analysis, 2021
15.12.2.1. By Product Type
15.12.2.2. By Technology
15.12.2.3. By End User
15.13. Japan
15.13.1. Pricing Analysis
15.13.2. Market Share Analysis, 2021
15.13.2.1. By Product Type
15.13.2.2. By Technology
15.13.2.3. By End User
15.14. South Korea
15.14.1. Pricing Analysis
15.14.2. Market Share Analysis, 2021
15.14.2.1. By Product Type
15.14.2.2. By Technology
15.14.2.3. By End User
15.15. India
15.15.1. Pricing Analysis
15.15.2. Market Share Analysis, 2021
15.15.2.1. By Product Type
15.15.2.2. By Technology
15.15.2.3. By End User
15.16. ASEAN
15.16.1. Pricing Analysis
15.16.2. Market Share Analysis, 2021
15.16.2.1. By Product Type
15.16.2.2. By Technology
15.16.2.3. By End User
15.17. Australia and New Zealand
15.17.1. Pricing Analysis
15.17.2. Market Share Analysis, 2021
15.17.2.1. By Product Type
15.17.2.2. By Technology
15.17.2.3. By End User
15.18. GCC Countries
15.18.1. Pricing Analysis
15.18.2. Market Share Analysis, 2021
15.18.2.1. By Product Type
15.18.2.2. By Technology
15.18.2.3. By End User
15.19. Turkey
15.19.1. Pricing Analysis
15.19.2. Market Share Analysis, 2021
15.19.2.1. By Product Type
15.19.2.2. By Technology
15.19.2.3. By End User
15.20. South Africa
15.20.1. Pricing Analysis
15.20.2. Market Share Analysis, 2021
15.20.2.1. By Product Type
15.20.2.2. By Technology
15.20.2.3. By End User
16. Market Structure Analysis
16.1. Competition Dashboard
16.2. Competition Benchmarking
16.3. Market Share Analysis of Top Players
16.3.1. By Regional
16.3.2. By Product Type
16.3.3. By Technology
16.3.4. By End User
17. Competition Analysis
17.1. Competition Deep Dive
17.1.1. Agilent Technologies
17.1.1.1. Overview
17.1.1.2. Product Portfolio
17.1.1.3. Profitability by Market Segments
17.1.1.4. Sales Footprint
17.1.1.5. Strategy Overview
17.1.1.5.1. Marketing Strategy
17.1.1.5.2. Product Strategy
17.1.1.5.3. Channel Strategy
17.1.2. Hologic
17.1.2.1. Overview
17.1.2.2. Product Portfolio
17.1.2.3. Profitability by Market Segments
17.1.2.4. Sales Footprint
17.1.2.5. Strategy Overview
17.1.2.5.1. Marketing Strategy
17.1.2.5.2. Product Strategy
17.1.2.5.3. Channel Strategy
17.1.3. Cepheid
17.1.3.1. Overview
17.1.3.2. Product Portfolio
17.1.3.3. Profitability by Market Segments
17.1.3.4. Sales Footprint
17.1.3.5. Strategy Overview
17.1.3.5.1. Marketing Strategy
17.1.3.5.2. Product Strategy
17.1.3.5.3. Channel Strategy
17.1.4. Qiagen
17.1.4.1. Overview
17.1.4.2. Product Portfolio
17.1.4.3. Profitability by Market Segments
17.1.4.4. Sales Footprint
17.1.4.5. Strategy Overview
17.1.4.5.1. Marketing Strategy
17.1.4.5.2. Product Strategy
17.1.4.5.3. Channel Strategy
17.1.5. Roche Diagnostics
17.1.5.1. Overview
17.1.5.2. Product Portfolio
17.1.5.3. Profitability by Market Segments
17.1.5.4. Sales Footprint
17.1.5.5. Strategy Overview
17.1.5.5.1. Marketing Strategy
17.1.5.5.2. Product Strategy
17.1.5.5.3. Channel Strategy
17.1.6. Bayer Healthcare
17.1.6.1. Overview
17.1.6.2. Product Portfolio
17.1.6.3. Profitability by Market Segments
17.1.6.4. Sales Footprint
17.1.6.5. Strategy Overview
17.1.6.5.1. Marketing Strategy
17.1.6.5.2. Product Strategy
17.1.6.5.3. Channel Strategy
17.1.7. Abbott Laboratories
17.1.7.1. Overview
17.1.7.2. Product Portfolio
17.1.7.3. Profitability by Market Segments
17.1.7.4. Sales Footprint
17.1.7.5. Strategy Overview
17.1.7.5.1. Marketing Strategy
17.1.7.5.2. Product Strategy
17.1.7.5.3. Channel Strategy
17.1.8. Grifols
17.1.8.1. Overview
17.1.8.2. Product Portfolio
17.1.8.3. Profitability by Market Segments
17.1.8.4. Sales Footprint
17.1.8.5. Strategy Overview
17.1.8.5.1. Marketing Strategy
17.1.8.5.2. Product Strategy
17.1.8.5.3. Channel Strategy
17.1.9. Danaher Corporation
17.1.9.1. Overview
17.1.9.2. Product Portfolio
17.1.9.3. Profitability by Market Segments
17.1.9.4. Sales Footprint
17.1.9.5. Strategy Overview
17.1.9.5.1. Marketing Strategy
17.1.9.5.2. Product Strategy
17.1.9.5.3. Channel Strategy
17.1.10. Siemens
17.1.10.1. Overview
17.1.10.2. Product Portfolio
17.1.10.3. Profitability by Market Segments
17.1.10.4. Sales Footprint
17.1.10.5. Strategy Overview
17.1.10.5.1. Marketing Strategy
17.1.10.5.2. Product Strategy
17.1.10.5.3. Channel Strategy
17.1.11. Beckton Dickinson
17.1.11.1. Overview
17.1.11.2. Product Portfolio
17.1.11.3. Profitability by Market Segments
17.1.11.4. Sales Footprint
17.1.11.5. Strategy Overview
17.1.11.5.1. Marketing Strategy
17.1.11.5.2. Product Strategy
17.1.11.5.3. Channel Strategy
17.1.12. Biomérieux Sa
17.1.12.1. Overview
17.1.12.2. Product Portfolio
17.1.12.3. Profitability by Market Segments
17.1.12.4. Sales Footprint
17.1.12.5. Strategy Overview
17.1.12.5.1. Marketing Strategy
17.1.12.5.2. Product Strategy
17.1.12.5.3. Channel Strategy
17.1.13. Sysmex Corporation
17.1.13.1. Overview
17.1.13.2. Product Portfolio
17.1.13.3. Profitability by Market Segments
17.1.13.4. Sales Footprint
17.1.13.5. Strategy Overview
17.1.13.5.1. Marketing Strategy
17.1.13.5.2. Product Strategy
17.1.13.5.3. Channel Strategy
18. Assumptions & Acronyms Used19. Research Methodology
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
List of Tables
Table 1: Global Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Forecast by Region, 2017-2032
Table 2: Global Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Forecast by Product Type, 2017-2032
Table 3: Global Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Forecast by Technology, 2017-2032
Table 4: Global Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Forecast by End User, 2017-2032
Table 5: North America Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 6: North America Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Forecast by Product Type, 2017-2032
Table 7: North America Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Forecast by Technology, 2017-2032
Table 8: North America Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Forecast by End User, 2017-2032
Table 9: Latin America Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 10: Latin America Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Forecast by Product Type, 2017-2032
Table 11: Latin America Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Forecast by Technology, 2017-2032
Table 12: Latin America Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Forecast by End User, 2017-2032
Table 13: Europe Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 14: Europe Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Forecast by Product Type, 2017-2032
Table 15: Europe Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Forecast by Technology, 2017-2032
Table 16: Europe Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Forecast by End User, 2017-2032
Table 17: East Asia Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 18: East Asia Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Forecast by Product Type, 2017-2032
Table 19: East Asia Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Forecast by Technology, 2017-2032
Table 20: East Asia Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Forecast by End User, 2017-2032
Table 21: South Asia & Pacific Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 22: South Asia & Pacific Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Forecast by Product Type, 2017-2032
Table 23: South Asia & Pacific Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Forecast by Technology, 2017-2032
Table 24: South Asia & Pacific Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Forecast by End User, 2017-2032
Table 25: MEA Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 26: MEA Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Forecast by Product Type, 2017-2032
Table 27: MEA Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Forecast by Technology, 2017-2032
Table 28: MEA Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Forecast by End User, 2017-2032
Find your sweet spots for generating winning opportunities in this market.
List of Charts
Figure 1: Global Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) by Product Type, 2022-2032
Figure 2: Global Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) by Technology, 2022-2032
Figure 3: Global Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) by End User, 2022-2032
Figure 4: Global Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) by Region, 2022-2032
Figure 5: Global Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Analysis by Region, 2017-2032
Figure 6: Global Colorectal Cancer Molecular Diagnostics Market Value Share (%) and BPS Analysis by Region, 2022-2032
Figure 7: Global Colorectal Cancer Molecular Diagnostics Market Y-o-Y Growth (%) Projections by Region, 2022-2032
Figure 8: Global Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Analysis by Product Type, 2017-2032
Figure 9: Global Colorectal Cancer Molecular Diagnostics Market Value Share (%) and BPS Analysis by Product Type, 2022-2032
Figure 10: Global Colorectal Cancer Molecular Diagnostics Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032
Figure 11: Global Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Analysis by Technology, 2017-2032
Figure 12: Global Colorectal Cancer Molecular Diagnostics Market Value Share (%) and BPS Analysis by Technology, 2022-2032
Figure 13: Global Colorectal Cancer Molecular Diagnostics Market Y-o-Y Growth (%) Projections by Technology, 2022-2032
Figure 14: Global Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Analysis by End User, 2017-2032
Figure 15: Global Colorectal Cancer Molecular Diagnostics Market Value Share (%) and BPS Analysis by End User, 2022-2032
Figure 16: Global Colorectal Cancer Molecular Diagnostics Market Y-o-Y Growth (%) Projections by End User, 2022-2032
Figure 17: Global Colorectal Cancer Molecular Diagnostics Market Attractiveness by Product Type, 2022-2032
Figure 18: Global Colorectal Cancer Molecular Diagnostics Market Attractiveness by Technology, 2022-2032
Figure 19: Global Colorectal Cancer Molecular Diagnostics Market Attractiveness by End User, 2022-2032
Figure 20: Global Colorectal Cancer Molecular Diagnostics Market Attractiveness by Region, 2022-2032
Figure 21: North America Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) by Product Type, 2022-2032
Figure 22: North America Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) by Technology, 2022-2032
Figure 23: North America Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) by End User, 2022-2032
Figure 24: North America Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) by Country, 2022-2032
Figure 25: North America Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 26: North America Colorectal Cancer Molecular Diagnostics Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 27: North America Colorectal Cancer Molecular Diagnostics Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 28: North America Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Analysis by Product Type, 2017-2032
Figure 29: North America Colorectal Cancer Molecular Diagnostics Market Value Share (%) and BPS Analysis by Product Type, 2022-2032
Figure 30: North America Colorectal Cancer Molecular Diagnostics Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032
Figure 31: North America Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Analysis by Technology, 2017-2032
Figure 32: North America Colorectal Cancer Molecular Diagnostics Market Value Share (%) and BPS Analysis by Technology, 2022-2032
Figure 33: North America Colorectal Cancer Molecular Diagnostics Market Y-o-Y Growth (%) Projections by Technology, 2022-2032
Figure 34: North America Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Analysis by End User, 2017-2032
Figure 35: North America Colorectal Cancer Molecular Diagnostics Market Value Share (%) and BPS Analysis by End User, 2022-2032
Figure 36: North America Colorectal Cancer Molecular Diagnostics Market Y-o-Y Growth (%) Projections by End User, 2022-2032
Figure 37: North America Colorectal Cancer Molecular Diagnostics Market Attractiveness by Product Type, 2022-2032
Figure 38: North America Colorectal Cancer Molecular Diagnostics Market Attractiveness by Technology, 2022-2032
Figure 39: North America Colorectal Cancer Molecular Diagnostics Market Attractiveness by End User, 2022-2032
Figure 40: North America Colorectal Cancer Molecular Diagnostics Market Attractiveness by Country, 2022-2032
Figure 41: Latin America Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) by Product Type, 2022-2032
Figure 42: Latin America Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) by Technology, 2022-2032
Figure 43: Latin America Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) by End User, 2022-2032
Figure 44: Latin America Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) by Country, 2022-2032
Figure 45: Latin America Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 46: Latin America Colorectal Cancer Molecular Diagnostics Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 47: Latin America Colorectal Cancer Molecular Diagnostics Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 48: Latin America Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Analysis by Product Type, 2017-2032
Figure 49: Latin America Colorectal Cancer Molecular Diagnostics Market Value Share (%) and BPS Analysis by Product Type, 2022-2032
Figure 50: Latin America Colorectal Cancer Molecular Diagnostics Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032
Figure 51: Latin America Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Analysis by Technology, 2017-2032
Figure 52: Latin America Colorectal Cancer Molecular Diagnostics Market Value Share (%) and BPS Analysis by Technology, 2022-2032
Figure 53: Latin America Colorectal Cancer Molecular Diagnostics Market Y-o-Y Growth (%) Projections by Technology, 2022-2032
Figure 54: Latin America Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Analysis by End User, 2017-2032
Figure 55: Latin America Colorectal Cancer Molecular Diagnostics Market Value Share (%) and BPS Analysis by End User, 2022-2032
Figure 56: Latin America Colorectal Cancer Molecular Diagnostics Market Y-o-Y Growth (%) Projections by End User, 2022-2032
Figure 57: Latin America Colorectal Cancer Molecular Diagnostics Market Attractiveness by Product Type, 2022-2032
Figure 58: Latin America Colorectal Cancer Molecular Diagnostics Market Attractiveness by Technology, 2022-2032
Figure 59: Latin America Colorectal Cancer Molecular Diagnostics Market Attractiveness by End User, 2022-2032
Figure 60: Latin America Colorectal Cancer Molecular Diagnostics Market Attractiveness by Country, 2022-2032
Figure 61: Europe Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) by Product Type, 2022-2032
Figure 62: Europe Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) by Technology, 2022-2032
Figure 63: Europe Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) by End User, 2022-2032
Figure 64: Europe Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) by Country, 2022-2032
Figure 65: Europe Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 66: Europe Colorectal Cancer Molecular Diagnostics Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 67: Europe Colorectal Cancer Molecular Diagnostics Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 68: Europe Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Analysis by Product Type, 2017-2032
Figure 69: Europe Colorectal Cancer Molecular Diagnostics Market Value Share (%) and BPS Analysis by Product Type, 2022-2032
Figure 70: Europe Colorectal Cancer Molecular Diagnostics Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032
Figure 71: Europe Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Analysis by Technology, 2017-2032
Figure 72: Europe Colorectal Cancer Molecular Diagnostics Market Value Share (%) and BPS Analysis by Technology, 2022-2032
Figure 73: Europe Colorectal Cancer Molecular Diagnostics Market Y-o-Y Growth (%) Projections by Technology, 2022-2032
Figure 74: Europe Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Analysis by End User, 2017-2032
Figure 75: Europe Colorectal Cancer Molecular Diagnostics Market Value Share (%) and BPS Analysis by End User, 2022-2032
Figure 76: Europe Colorectal Cancer Molecular Diagnostics Market Y-o-Y Growth (%) Projections by End User, 2022-2032
Figure 77: Europe Colorectal Cancer Molecular Diagnostics Market Attractiveness by Product Type, 2022-2032
Figure 78: Europe Colorectal Cancer Molecular Diagnostics Market Attractiveness by Technology, 2022-2032
Figure 79: Europe Colorectal Cancer Molecular Diagnostics Market Attractiveness by End User, 2022-2032
Figure 80: Europe Colorectal Cancer Molecular Diagnostics Market Attractiveness by Country, 2022-2032
Figure 81: East Asia Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) by Product Type, 2022-2032
Figure 82: East Asia Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) by Technology, 2022-2032
Figure 83: East Asia Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) by End User, 2022-2032
Figure 84: East Asia Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) by Country, 2022-2032
Figure 85: East Asia Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 86: East Asia Colorectal Cancer Molecular Diagnostics Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 87: East Asia Colorectal Cancer Molecular Diagnostics Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 88: East Asia Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Analysis by Product Type, 2017-2032
Figure 89: East Asia Colorectal Cancer Molecular Diagnostics Market Value Share (%) and BPS Analysis by Product Type, 2022-2032
Figure 90: East Asia Colorectal Cancer Molecular Diagnostics Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032
Figure 91: East Asia Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Analysis by Technology, 2017-2032
Figure 92: East Asia Colorectal Cancer Molecular Diagnostics Market Value Share (%) and BPS Analysis by Technology, 2022-2032
Figure 93: East Asia Colorectal Cancer Molecular Diagnostics Market Y-o-Y Growth (%) Projections by Technology, 2022-2032
Figure 94: East Asia Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Analysis by End User, 2017-2032
Figure 95: East Asia Colorectal Cancer Molecular Diagnostics Market Value Share (%) and BPS Analysis by End User, 2022-2032
Figure 96: East Asia Colorectal Cancer Molecular Diagnostics Market Y-o-Y Growth (%) Projections by End User, 2022-2032
Figure 97: East Asia Colorectal Cancer Molecular Diagnostics Market Attractiveness by Product Type, 2022-2032
Figure 98: East Asia Colorectal Cancer Molecular Diagnostics Market Attractiveness by Technology, 2022-2032
Figure 99: East Asia Colorectal Cancer Molecular Diagnostics Market Attractiveness by End User, 2022-2032
Figure 100: East Asia Colorectal Cancer Molecular Diagnostics Market Attractiveness by Country, 2022-2032
Figure 101: South Asia & Pacific Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) by Product Type, 2022-2032
Figure 102: South Asia & Pacific Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) by Technology, 2022-2032
Figure 103: South Asia & Pacific Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) by End User, 2022-2032
Figure 104: South Asia & Pacific Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) by Country, 2022-2032
Figure 105: South Asia & Pacific Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 106: South Asia & Pacific Colorectal Cancer Molecular Diagnostics Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 107: South Asia & Pacific Colorectal Cancer Molecular Diagnostics Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 108: South Asia & Pacific Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Analysis by Product Type, 2017-2032
Figure 109: South Asia & Pacific Colorectal Cancer Molecular Diagnostics Market Value Share (%) and BPS Analysis by Product Type, 2022-2032
Figure 110: South Asia & Pacific Colorectal Cancer Molecular Diagnostics Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032
Figure 111: South Asia & Pacific Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Analysis by Technology, 2017-2032
Figure 112: South Asia & Pacific Colorectal Cancer Molecular Diagnostics Market Value Share (%) and BPS Analysis by Technology, 2022-2032
Figure 113: South Asia & Pacific Colorectal Cancer Molecular Diagnostics Market Y-o-Y Growth (%) Projections by Technology, 2022-2032
Figure 114: South Asia & Pacific Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Analysis by End User, 2017-2032
Figure 115: South Asia & Pacific Colorectal Cancer Molecular Diagnostics Market Value Share (%) and BPS Analysis by End User, 2022-2032
Figure 116: South Asia & Pacific Colorectal Cancer Molecular Diagnostics Market Y-o-Y Growth (%) Projections by End User, 2022-2032
Figure 117: South Asia & Pacific Colorectal Cancer Molecular Diagnostics Market Attractiveness by Product Type, 2022-2032
Figure 118: South Asia & Pacific Colorectal Cancer Molecular Diagnostics Market Attractiveness by Technology, 2022-2032
Figure 119: South Asia & Pacific Colorectal Cancer Molecular Diagnostics Market Attractiveness by End User, 2022-2032
Figure 120: South Asia & Pacific Colorectal Cancer Molecular Diagnostics Market Attractiveness by Country, 2022-2032
Figure 121: MEA Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) by Product Type, 2022-2032
Figure 122: MEA Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) by Technology, 2022-2032
Figure 123: MEA Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) by End User, 2022-2032
Figure 124: MEA Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) by Country, 2022-2032
Figure 125: MEA Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 126: MEA Colorectal Cancer Molecular Diagnostics Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 127: MEA Colorectal Cancer Molecular Diagnostics Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 128: MEA Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Analysis by Product Type, 2017-2032
Figure 129: MEA Colorectal Cancer Molecular Diagnostics Market Value Share (%) and BPS Analysis by Product Type, 2022-2032
Figure 130: MEA Colorectal Cancer Molecular Diagnostics Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032
Figure 131: MEA Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Analysis by Technology, 2017-2032
Figure 132: MEA Colorectal Cancer Molecular Diagnostics Market Value Share (%) and BPS Analysis by Technology, 2022-2032
Figure 133: MEA Colorectal Cancer Molecular Diagnostics Market Y-o-Y Growth (%) Projections by Technology, 2022-2032
Figure 134: MEA Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Analysis by End User, 2017-2032
Figure 135: MEA Colorectal Cancer Molecular Diagnostics Market Value Share (%) and BPS Analysis by End User, 2022-2032
Figure 136: MEA Colorectal Cancer Molecular Diagnostics Market Y-o-Y Growth (%) Projections by End User, 2022-2032
Figure 137: MEA Colorectal Cancer Molecular Diagnostics Market Attractiveness by Product Type, 2022-2032
Figure 138: MEA Colorectal Cancer Molecular Diagnostics Market Attractiveness by Technology, 2022-2032
Figure 139: MEA Colorectal Cancer Molecular Diagnostics Market Attractiveness by End User, 2022-2032
Figure 140: MEA Colorectal Cancer Molecular Diagnostics Market Attractiveness by Country, 2022-2032
